Found 6 matching trials
Vaccine Study of MVA-MUC1-IL2 in Patients With Prostate Cancer PHASE2 This study involves the use of an experimental product, TG4010. The purpose...
Show More Location
Arizona Cancer Center
Learn More & Join Trial
Vaccine Therapy in Treating Patients With Advanced Cancer PHASE1 RATIONALE: Vaccines may make the body build an immune response to kill tumo...
Show More Location
Jonsson Comprehensive Cancer Center, UCLA
Learn More & Join Trial
A Study Evaluating the Efficacy and the Safety of First-line Chemotherapy Combined With the Therapeutic Vaccine Named TG4010 and Nivolumab in Patients With Advanced Non-squamous Non-Small Cell Lung Cancer (NSCLC) PHASE2 This is a multicenter, single arm, open label phase II study in treatment-n...
Show More Learn More & Join Trial
TG4010 and Nivolumab in Patients With Lung Cancer PHASE2 This phase II trial studies how well TG4010 and nivolumab work in previousl...
Show More Location
City of Hope Comprehensive Cancer Center
Learn More & Join Trial
Immunotherapy With TG4010 in Patients With Advanced Non-Small Cell Lung Cancer PHASE2 The primary Objective is to assess the efficacy of TG4010 combined to chemo...
Show More Location
Centre Hospitalier Belfort-Montbeliard
Learn More & Join Trial
Phase IIB/III Of TG4010 Immunotherapy In Patients With Stage IV Non-Small Cell Lung Cancer PHASE2 This is a Phase IIb/III randomized, double-blind, placebo-controlled study ...
Show More Location
Mayo Clinic Arizona
Learn More & Join Trial